Home » Newsletters » BioWorld Science

BioWorld Science

March 3, 2005

View Archived Issues

Dopamine transporter ligand identified with potential efficacy as a treatment for cocaine addiction

Mechanism of action of the antiinflammatory effects of erythromycin in vivo

NCX-4016 reported to decrease platelet activation in patients with type 2 diabetes

Good safety profile found for Adenovirus Type-5 HIV vaccines in healthy subjects

Cytolin decreases viral load and increases T-cell count in HIV-infected patients

Pharmacopeia and Celgene select compound for development

3M and Takeda sign agreement for HPV infection and cervical dysplasia

Helix subsidiary signs agreement with Apotex

A novel PAR2 agonist induces gastric mucosal cytoprotection

Second phase I study for MPC-6827

OSI-930 enters clinical development

Mechanisms of CB2 cannabinoid receptor antinociception

Phase II study for antianxiety agent MN-305

Mechanism of action of the HIV-1 attachment inhibitor, BMS-488043

Full enrollment reached in phase II MATCHED study of MC-4232

SP-01A set to enter phase II/III study in Q2

GenPath becomes AVEO Pharmaceuticals

OccuLogix cleared to begin crossover studies of RHEO system for dry AMD

Preclinical activity of a novel nonpeptide selective vasopressin V1A receptor antagonist, YM-218

Non-approvable letter for Lexapro in panic disorder

Exubera NDA accepted for filing

Norpiperidine imidazoazepines: a novel class of selective nonsedative H1 antihistamines

New opioid receptor antagonists for gastrointestinal dysfunction disclosed by Adolor

AstraZeneca claims novel Aurora kinase inhibitors for the treatment of cancer

New cannabinoid CB1 receptor modulators prepared and tested at AstraZeneca

New treatment for varicose veins described in patent literature

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...